Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Playing CLL / SLL Chess: Planning Your Therapy Moves

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

Recorded October 26, 2022

Treating CLL / SLL is a little like a chess game, as one needs to always be thinking a few moves ahead. Most treatments for CLL / SLL are not curative, and when relapse occurs it is important to have a plan in place with some options that can knock back the disease again.

Join CLL / SLL expert Dr. Susan O’Brien, and 20-year CLL survivor Terry Evans, as they explain the CLL / SLL treatment landscape, what is known and unknown, and describe how to better participate in shared decision-making with your healthcare provider by increasing your knowledge and having a plan in place for your future treatment moves.



Brian Koffman, MDCM (retired), MS Ed
Co-Founder, Executive Vice President, and Chief Medical Officer
CLL Society 


Susan O’Brien, MD
Professor of Medicine
University of California, Irvine


Terry Evans - CLL Society

Terry Evans
22-year CLL Patient and Advocate
Director, CLL Society Support Network

Deep Dive into Five Podcast

Join CLL / SLL expert Dr. Susan O’Brien, and 22-year CLL survivor Terry Evans, for this fast-paced podcast / webcast as they dive deeper into this topic with five questions in roughly 15 minutes.

This program is made possible by support from BeiGene, Bristol Myers Squibb, Lilly Oncology, Genentech, and Janssen. 

Supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.